1WHO Scientific Working Group on monitoring and management of bacterial resistance to antimicrobial agents. Bacterial, viral diseases and immunology.Geneva : Would Health Organization, 1994.
2R Fuller. Probiotics in human medicine. Gut, 1991,32:439 - 442.
3E Lsolauri, P V Kirjavainen, S Salminen. Probiotics:a role in the treatment of intestinal infection and inflammation? Gut 2002,.50( Suppl Ⅲ ) : 54 - 59.
4Rial D. Rolfe. The role of probiotics cultures in the control of gastrointestinal health. J. Nutr. 1998,130:396S - 4013 -2318.
5Karen Madsen,Anthony Corrish,Paul Soper, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroentrology.2001,121(3) :580 - 591.
6Tanja Pessi, Yelda Sutas, Aulis Marttinen, et al. Probiotics reinforce mucosal degradation of antigens in rats:implications for therapeutic use of probiotics.J.Nutr. 128:23per, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology September, 2001,121,(3): 580- 591.
7Jin L, Marquart R, Zhao X. A strain of enterocoecus faecium( 18C23)inhibits the adhesion of enterotoxigenic Escerichia Coli K88 to porcine small intestinal mucus. Appl Environ Microbiol, 2000,66 : 4200 - 4204.
8Flynn S, Van Sinderen D, Thornton G M, et al. Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium lactobacillus salivarius subsp, sativarius UCC118. Microbiology,2002,148(pt 4) ,973 - 984.
9Dunne C, L Murphy, S Flynn, et al. Probiotics, from myth to reality.Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek, 1999,76:279 - 292.
10Harms HK, Bertele Harms RM, Bruer Kleis D. Enzyme substitution therapy with the yeast saccharomyces cerevisiae in congenital sucrase-isomaltase deficiency. N Engl J Meal, 1987,316:1306 - 1309.
4Guandalnini Si, Pensabene L,Zikri MA, et al.Lact obacillus GG administe red in Orel rehydration so lution to children with acute diarrhea: a multcenter European trial [J].Pedietr Gast Poen Terol Nutr, 2000,30(2):214-216.
5Cleary RK. Clostridium difficile associated diarrhea and colitis: clinical manifestations, diagnosis, and treatment [J]. Dis Colon Rectum, 1998, 41(11): 1435-1449.
6Isolauri E. Probiotics in human disease [J]. Am J Clin Nutr, 2001, 73: 1142-1146.
7Malin M, Suomalainen H, Saxein M, et al. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG [J]. Ann Nutr Metab, 1996, 40: 137-145.
